| 000 | 01420 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518035447.0 | ||
| 264 | 0 | _c20200812 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a2163-8306 | ||
| 024 | 7 |
_a10.1002/psp4.12408 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Diansong | |
| 245 | 0 | 0 |
_aEvaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach. _h[electronic resource] |
| 260 |
_bCPT: pharmacometrics & systems pharmacology _c07 2019 |
||
| 300 |
_a489-499 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBenzamides _xpharmacokinetics |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aPyrazines _xpharmacokinetics |
| 700 | 1 | _aPodoll, Terry | |
| 700 | 1 | _aXu, Yan | |
| 700 | 1 | _aMoorthy, Ganesh | |
| 700 | 1 | _aVishwanathan, Karthick | |
| 700 | 1 | _aWare, Joseph | |
| 700 | 1 | _aSlatter, J Greg | |
| 700 | 1 | _aAl-Huniti, Nidal | |
| 773 | 0 |
_tCPT: pharmacometrics & systems pharmacology _gvol. 8 _gno. 7 _gp. 489-499 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/psp4.12408 _zAvailable from publisher's website |
| 999 |
_c29646935 _d29646935 |
||